Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Xavier Ansolabehere"'
Publikováno v:
International journal of clinical pharmacology and therapeutics. 57(9)
Objective Antipsychotics exhibit different profiles of efficacy and safety in patients with schizophrenia. It has recently been reported that the risk of rehospitalization was the lowest with paliperidone palmitate (PP), a long-acting injectable (LAI
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b98760659ea4abf95007e190aa582114
https://pubmed.ncbi.nlm.nih.gov/31232279
https://pubmed.ncbi.nlm.nih.gov/31232279
Autor:
R. Morlock, Laura Horne, Pierre Chevalier, Dionne M. Hines, Xavier Ansolabehere, Lalitha Aiyer, C. Storgard, Fredrik Nyberg, Javier Nuevo
Publikováno v:
Advances in Therapy
Introduction Patients with gout have numerous comorbidities. We aimed to estimate the prevalence and incidence rates of renal and cardiovascular morbidities in trial-aligned patients with established gout in Germany (DE), the United Kingdom (UK), the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d8a678e0bd6479ecb86213b7b6e93e9
http://europepmc.org/articles/PMC4939171
http://europepmc.org/articles/PMC4939171
Autor:
Werner Nindl, Laurent Misery, Pierre Wolkenstein, Nathalie Baudot, Mao-Jie Cheng, Juan Antonio Sánchez Gaviño, Emmanouil Angelakis, Angela Weihong Yang, Yumiko Inoue, E.M. Garcia-Martinez, Nadine Franzke, Satz Mengensatzproduktion, Anne Isvy-Joubert, Charlie Changli Xue, S. Steinke, Natalia Palmou-Fontana, Werner Druck Medien Ag, Huan Yang, Ling Zhang, Werner Aberer, A Langenbruch, Salim Trad, Jean-Pierre Gaitz, Susana Puig, Laurence Valeyrie-Allanore, Dennis McGonagle, Sonja Ständer, Renaud Vincent, Barbara C. Böckle, Rudolf Happle, Chun Guang Li, Camille Francès, Patricia Senet, Cynthia Haddad, Coralie Barbe, David Jara, Charles Taieb, Goretti Lacruz, Olivier Chosidow, Wen-Chieh Chen, Antonis Germanakis, Jean-Michel Race, Norbert T. Sepp, Nathalie Grandfils, Zhi-Qiang Song, Chuanjian Lu, Jean-Hilaire Saurat, Yang Chen, Yuedi Wang, Isabel Cárdenas, Olivier Sorg, Josep Malvehy, Alba Díaz, Matthias Augustin, Zhu Shen, Luis Iñiguez de Onzoño Martín, Dimosthenis Chochlakis, Xavier Ansolabehere, Joan Anton Puig-Butille, Saskia Ingen-Housz-Oro, Cristina Carrera, Yannis Tselentis, Yuichi Teraki, Victor Georgescu, Sherman Gu, Fanny Fichel, Anna Psaroulaki, Haizhou Zhou, Celia Badenas
Publikováno v:
Dermatology. 228:I-IV
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b5b6a14e4d589b33493b92a97bf7dbe6
https://doi.org/10.1159/000365641
https://doi.org/10.1159/000365641
Publikováno v:
Dermatology (Basel, Switzerland). 228(4)
The frequency of associated comorbidity and the cost of treatments in patients with atopic dermatitis (AD) followed up in primary care settings are poorly known. We carried out a retrospective cohort study on a longitudinal electronic medical records
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1f24063a47854e06749c059d0c6e2e78
https://pubmed.ncbi.nlm.nih.gov/24662194
https://pubmed.ncbi.nlm.nih.gov/24662194
Autor:
Laura Horne, C. Storgard, Fredrik Nyberg, Pierre Chevalier, Dionne M. Hines, L. Aiyer, Javier Nuevo, Xavier Ansolabehere, R. Morlock
Publikováno v:
Annals of the Rheumatic Diseases. 74:552.2-552
Background Hyperuricemia and gout are increasingly prevalent, and if not appropriately treated, may cause permanent joint destruction, bone erosion, and kidney damage. Patients typically have worse-than-normal pre-existing health status at diagnosis,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::38f45348084724b8c6746b619935d370
https://doi.org/10.1136/annrheumdis-2015-eular.3634
https://doi.org/10.1136/annrheumdis-2015-eular.3634
Autor:
Laura Horne, Fredrik Nyberg, Dionne M. Hines, Xavier Ansolabehere, R. Morlock, L. Aiyer, C. Storgard, Pierre Chevalier, Javier Nuevo
Publikováno v:
Annals of the Rheumatic Diseases. 74:549.2-550
Background Gout affects 1–4% of the population in developed Western countries. The goal of gout treatment is lowering serum uric acid (sUA) levels to treat and prevent urate crystal deposition, thereby improving signs and symptoms of gout, e.g., ac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5f35ab0b10f5790f5dd9bb04e22ffaf2
https://doi.org/10.1136/annrheumdis-2015-eular.5007
https://doi.org/10.1136/annrheumdis-2015-eular.5007
Autor:
Javier Nuevo, Dionne M. Hines, Xavier Ansolabehere, R. Morlock, Pierre Chevalier, Laura Horne, C. Storgard, Fredrik Nyberg, Lalitha Aiyer
Publikováno v:
Rheumatology and Therapy. 3(1):53-75
The present study aimed to assess disease control, health resource utilization (HRU), and healthcare costs, and their predictors in gout patients across the USA, UK, Germany, and France.Data were extracted from the PharMetrics Plus (USA), Clinical Pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::79042d13aa0c7a21420619f4662150fd
Publikováno v:
Allergy; Jul2019, Vol. 74 Issue 7, p1215-1218, 4p
Autor:
Divino, Victoria1 (AUTHOR) Victoria.Divino@IQVIA.com, Boye, Kristina S.2 (AUTHOR), Lebrec, Jeremie3 (AUTHOR), DeKoven, Mitch1 (AUTHOR), Norrbacka, Kirsi4 (AUTHOR)
Publikováno v:
Diabetes Therapy. Jun2019, Vol. 10 Issue 3, p1067-1088. 22p.
Autor:
Divino, Victoria1 victoria.divino@quintilesims.com, DeKoven, Mitch1, Khan, Farhad2, Boye, Kristina3, Sapin, Hélène4, Norrbacka, Kirsi5
Publikováno v:
Diabetes Therapy. Feb2017, Vol. 8 Issue 1, p115-128. 14p.